|
 |
|
|
|
| |
|
|
|
|
| Table 12. HIV-infected patients currently prescribed primary Pneumocystis carinii pneumonia (PCP) prophylaxis by data source and sex |
|
|
|
|
View PDF
|
|
Data in Tables 11-13 are based on the following analyses:
- In ASD (1999) and SHDC (1998), what proportion of eligible1 patients were prescribed primary prophylaxis for PCP?
|
 |
|
|
|
|
|
|
|
|
| Data Source |
Total |
|
Male |
|
Female |
| % |
Treated/
Eligible |
% |
Treated/
Eligible |
% |
Treated/
Eligible |
| ASD |
60 |
2,848/4,771 |
|
62 |
2,218/3,591 |
|
53 |
630/1,180 |
| SHDC Site A |
55 |
96/174 |
52 |
60/116 |
64 |
37/58 |
| SHDC Site B |
58 |
73/125 |
54 |
45/83 |
67 |
28/42 |
| SHDC Site C |
67 |
136/203 |
67 |
106/158 |
76 |
34/45 |
|
|
|
- In ASD, a higher proportion of eligible males were prescribed PCP prophylaxis than females.
- All SHDC sites had a greater proportion of eligible females prescribed prophylaxis compared with males.
Data from the SHAS and MOPTB studies were not available for this question.
|
|
|
| 1 |
Patients who have been previously diagnosed with PCP were excluded from this analysis because they are not eligible for primary prophylaxis.
|
|
|
|
|
|
|
|
|
|
